Siyi Xiong

Southwest Hospital

Papers

1

Total Citations

50

H-Index

1

About

Siyi Xiong is a leading voice in surgical oncology, best known for pioneering work that redefines the balance between oncologic safety and minimally invasive techniques. Her research centers on breast cancer surgery, with a particular focus on evaluating the long-term prognostic outcomes of minimal access breast surgery (MABS) compared to conventional breast surgery (CBS). Xiong’s landmark 2022 study, which has garnered over 50 citations, directly addressed a critical gap in the literature by providing robust, long-term data on the oncologic efficacy of MABS. This work has been instrumental in challenging traditional surgical paradigms, offering evidence that less invasive approaches can be safely adopted without compromising patient survival. Beyond this key contribution, Xiong’s research continues to shape clinical guidelines, advocating for patient-centered care that prioritizes both cosmetic outcomes and rigorous cancer control. Her findings are widely cited by surgeons and oncologists seeking to integrate modern techniques into practice, cementing her reputation as a transformative figure in breast cancer management.

Research Focus

Key Achievements

1
H-Index
1
Papers
50
Total Citations
50
Avg Citations/Paper
🏆 Most Cited Paper
Association of Long-term Oncologic Prognosis With Minimal Access Breast Surgery vs Conventional Breast Surgery
50 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Southwest Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago